FLNA Gene Cardiac valvular dysplesia X-linked Genetic Test
Components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test type: Cardiovascular Pneumology Disorders
- Doctor: Cardiologist
- Test Department: Genetics
Pre Test Information:
Clinical History of Patient who is going for FLNA Gene Cardiac valvular dysplesia, X-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLNA Gene Cardiac valvular dysplesia, X-linked NGS Genetic DNA Test gene FLNA.
Test Details:
FLNA gene, also known as Filamin A gene, is associated with a condition called Cardiac valvular dysplasia, X-linked. This genetic disorder affects the development of heart valves, leading to abnormal structure and function. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing method that utilizes high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations and variations in a person’s DNA.
In the context of Cardiac valvular dysplasia, X-linked, an NGS Genetic Test can be used to identify mutations or variations in the FLNA gene. This can help in diagnosing individuals with the condition, as well as providing information about the specific genetic variant causing the disorder.
NGS Genetic Test for FLNA gene can be performed on a blood or saliva sample. The sample is sequenced using advanced sequencing technologies, and the resulting data is analyzed to identify any mutations or variations in the FLNA gene.
The results of the NGS Genetic Test can provide valuable information for healthcare professionals in managing and treating individuals with Cardiac valvular dysplasia, X-linked. It can help in determining the best course of treatment, monitoring disease progression, and providing genetic counseling to affected individuals and their families.
Test Name | FLNA Gene Cardiac valvular dysplesia X-linked Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Cardiovascular Pneumology Disorders |
Doctor | Cardiologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for FLNA Gene Cardiac valvular dysplesia, X-linked NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with FLNA Gene Cardiac valvular dysplesia, X-linked NGS Genetic DNA Test gene FLNA |
Test Details |
FLNA gene, also known as Filamin A gene, is associated with a condition called Cardiac valvular dysplasia, X-linked. This genetic disorder affects the development of heart valves, leading to abnormal structure and function. NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing method that utilizes high-throughput sequencing technologies to analyze multiple genes simultaneously. It allows for the detection of various genetic mutations and variations in a person’s DNA. In the context of Cardiac valvular dysplasia, X-linked, an NGS Genetic Test can be used to identify mutations or variations in the FLNA gene. This can help in diagnosing individuals with the condition, as well as providing information about the specific genetic variant causing the disorder. NGS Genetic Test for FLNA gene can be performed on a blood or saliva sample. The sample is sequenced using advanced sequencing technologies, and the resulting data is analyzed to identify any mutations or variations in the FLNA gene. The results of the NGS Genetic Test can provide valuable information for healthcare professionals in managing and treating individuals with Cardiac valvular dysplasia, X-linked. It can help in determining the best course of treatment, monitoring disease progression, and providing genetic counseling to affected individuals and their families. |